ReviewTherapeutic advances in gastroenterology2025
Utilizing large language models for gastroenterology research: a conceptual framework.
Review in Therapeutic advances in gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Large language models' performance in answering common patient questions about colonoscopy: an expert-based evaluation.BMC gastroenterology · 2026Observational
- Automated identification of keratinocyte cancers in pathology reports using large language models.PLOS digital health · 2026Article
- Performance comparison of a neuro-symbolic large language model system versus conventional AI models and human experts in cholangitis management.BMC medical informatics and decision making · 2026Article
- Large Language Models for Diagnosis and Prognosis of Chronic Liver Diseases: A Systematic Review.Health science reports · 2026Review
- [Dual role of tea consumption in gastrointestinal disease risks: analysis using a risk prediction model integrating interpretable machine learning and large language model].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026Article
- [Clinical Implementation of Artificial Intelligence in Endoscopy: A Human-Artificial Intelligence Interaction Perspective].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2026Review
- Responsible use of large language models in gastroenterology and hepatology.Therapeutic advances in gastroenterology · 2026Review
- Artificial Intelligence and the future of clinical trials.Contemporary clinical trials communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large language models (LLMs) transform healthcare by assisting clinicians with decision-making, research, and patient management. In gastroenterology, LLMs have shown potential in clinical decision support, data extraction, and patient education. However, challenges such as bias, hallucinations, integration with clinical workflows, and regulatory compliance must be addressed for safe and effective implementation. This manuscript presents a structured framework for integrating LLMs into gastroenterology, using Hepatitis C treatment as a real-world application. The framework outlines key steps to ensure accuracy, safety, and clinical relevance while mitigating risks associated with artificial intelligence (AI)-driven healthcare tools. The framework includes defining clinical goals, assembling a multidisciplinary team, data collection and preparation, model selection, fine-tuning, calibration, hallucination mitigation, user interface development, integration with electronic health records, real-world validation, and continuous improvement. Retrieval-augmented generation and fine-tuning approaches are evaluated for optimizing model adaptability. Bias detection, reinforcement learning from human feedback, and structured prompt engineering are incorporated to enhance reliability. Ethical and regulatory considerations, including the Health Insurance Portability and Accountability Act, General Data Protection Regulation, and AI-specific guidelines (DECIDE-AI, SPIRIT-AI, CONSORT-AI), are addressed to ensure responsible AI deployment. LLMs have the potential to enhance decision-making, research efficiency, and patient care in gastroenterology, but responsible deployment requires bias mitigation, transparency, and ongoing validation. Future research should focus on multi-institutional validation and AI-assisted clinical trials to establish LLMs as reliable tools in gastroenterology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.